Haemopoietic progenitors in different parts of one femur perform different functions during regeneration

Femoral haemopoietic tissue was divided into cells released by flushing and cells released by grinding and washing flushed femora. The flushed femur contained 5 times more nucleated cells than the ground femur, 40 times more macrophage colony-forming cells and 6 times more developmentally late, day 8, and developmentally early, day 13, spleen colony-forming cells. However, the ground femur contained 2 times more developmentally early high proliferation potential colony-forming cells and 3 times more late ones. Haemopoietic regeneration of mice treated with fluorouracil was compared in samples obtained by flushing alone and grinding flushed femora. The number of nucleated cells recovered by flushing fell thirteen-fold by the sixth day after administration of the drug and the number recovered by grinding fell six-fold by the eighth day. Developmentally early high-proliferation-potential colony-forming cells which were recovered by grinding doubled their number in half the time taken by similar cells recovered by flushing. These observations are consistent with haemopoietic cells in different parts of the same bone performing different functions during regeneration. Large numbers of high-proliferation-potential colony-forming cells were not found in the circulation until 8 days after treatment with fluorouracil. Five days after mice had been treated with fluorouracil, when their blood forming systems were regenerating, early high-proliferation-potential colony-forming cells in one sample of marrow were derived from different founder cells than were late cells in the same sample. At the same time, early high-proliferation-potential colony-forming cells in the ground sample of a femur were derived from different founder cells than were cells at the same stage of development in the flushed sample of the femur. These observations are consistent with the view that haemopoietic regeneration after treatment with fluorouracil is due to the growth of few founder cells whose progeny have migrated little within 5 days of drug treatment.